BETA

IPO registrations (S-1, F-1) · Registrants

MOMENTA PHARMACEUTICALS INC

SEC CIK
1235010 · filings on EDGAR ↗
Registration
Form S-1, first filed 2004-03-11, last 2004-06-21; 1 initial registration, 6 amendments
Outcome
Final prospectus filed 2004-06-22
Industry (SIC)
Biological Products, (No Diagnostic Substances) 2836
Incorporated in
DE
Business address
301 BINNEY STREET, Cambridge, MA 02142
EIN
04-3561634
EDGAR entity type
operating
Insiders and CEO pay
MOMENTA PHARMACEUTICALS INC on the corporate pages

Offering terms

Proposed price range
$6.50–$7.00 per share (S-1/A filed 2004-06-21)
Final price
$6.50 per share, within the range (424B4 filed 2004-06-22, an initial public offering)
Shares sold
5,350,000
Gross proceeds
$34,775,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol MNTA
Lead underwriters
Cowen (1,952,750 shares); BofA Securities (1,952,750 shares)
Syndicate
CIBC World Markets (1,070,000); ThinkEquity (374,500)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 8

FiledFormWhat it isName as filedEDGAR
2004-03-11S-1S-1 (registration)MOMENTA PHARMACEUTICALS INC0001047469-04-007521 ↗
2004-04-16S-1/AS-1/A (amendment)MOMENTA PHARMACEUTICALS INC0001047469-04-012383 ↗
2004-05-11S-1/AS-1/A (amendment)MOMENTA PHARMACEUTICALS INC0001047469-04-016866 ↗
2004-05-21S-1/AS-1/A (amendment)MOMENTA PHARMACEUTICALS INC0001047469-04-018211 ↗
2004-06-15S-1/AS-1/A (amendment)MOMENTA PHARMACEUTICALS INC0001047469-04-020626 ↗
2004-06-18S-1/AS-1/A (amendment)MOMENTA PHARMACEUTICALS INC0001047469-04-021007 ↗
2004-06-21S-1/AS-1/A (amendment)MOMENTA PHARMACEUTICALS INC0001047469-04-021106 ↗
2004-06-22424B4424B4 (final prospectus)MOMENTA PHARMACEUTICALS INC0001047469-04-021219 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2004-06-21S-1/Aregistration statement$6.50–$7.005,350,000-Nasdaq MNTA4primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4document ↗
2004-06-22424B4final prospectus$6.505,350,000$34,775,000Nasdaq MNTA4primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Crane Alan LDirector; Director,Officer; OtherC.E.O.; President, C.E.O.; President, CEO252006–2010
Kaundinya Ganesh VenkataramanOfficerCOO & CSO; Senior V.P., Research; Senior VP, Research1352006–2018
Bishop John EOfficerSenior VP, Pharmaceutical Scie; VP Pharma Sciences & Manufact1322006–2016
Brugger Stephen BOfficerChief Operating Officer; Senior Vice President; Sr. V.P., Strat. Bus. Ops.202006–2010
Shea Richard POfficerSVP, CFO; VP, CFO1042006–2016person page Fuzzy
Whoriskey Susan KOfficerV.P., Lic. & Bus. Dev.; VP, Lic. & Bus. Dev.92006–2007
Lisa Carron ShmerlingOfficerV.P., Legal Affairs32006–2007
Sasisekharan RamDirector322006–2010
GOLDENHEIM PAUL DDirector22006person page Fuzzy
Barrett PeterDirector42006–2008
CLARKE JOHN KDirector142006–2015
HUTT PETER BARTONDirector132006–2014
LANGER ROBERTDirector62006–2008
Reeders Stephen TDirector52006–2008
Shapiro Bennett MDirector452006–2016
Fanucci MarshaDirector132006–2016
NOVARTIS AGTenPercentOwner12006
WHEELER CRAIG ADirector,OfficerPresident; President & CEO1552006–2020person page Fuzzy
Stoner ElizabethDirector342007–2020
Roach James M.OfficerSenior VP, Development and Chi782008–2016
SULAT JAMES RDirector192008–2019
Leicher BruceOfficerSVP & General Counsel1062008–2018
DOWNEY BRUCEDirector172009–2020
Koestler Thomas PDirector102011–2019person page Fuzzy
Franken MichaelOfficerPresident, Biosimilars Busines92013–2015
Ottmer Matthew P.OfficerChief Operating Officer42015–2017
GEMAYEL GEORGESDirector92016–2020
Guiterrez-Ramos Jose CarlosDirector92016–2020person page Fuzzy
GILMAN STEVEN CDirector112016–2020
Fishman Corey N.Director62016–2019
Storer Scott MOfficerSVP, CFO32016–2018
Arroyo SantiagoOfficerSVP, Chief Medical Officer272017–2020
KWON YOUNGOfficerChief Financial & Bus. Officer; SVP, Chief Business Officer; SVP, Corporate Development432018–2020
BELTRAMELLO JO ANNOfficerChief HR and Inf. Officer472018–2020
Carvajal AlejandraOfficerChief Legal Officer222018–2020
FIER IANOfficerChief Mfg and Program Officer452018–2020
Manning Anthony M.OfficerChief Scientific Officer402018–2020
ROBERTSON MICHELLEOfficerChief Financial Officer82018–2019
GROGAN DONNA ROYDirector42019–2020
Barlow Jane FDirector42019–2020
Cieplinska AgnieszkaOfficerChief Accounting Officer (PAO); VP Finance, Controller (PAO); VP FINANCE, CONTROLLER (PAO)62020

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Lobbying clientMOMENTA PHARMACEUTICALS, INC.MAFederal lobbying (LDA)name and state
Lobbying clientMOMENTA PHARMACEUTICALS, INC.MAFederal lobbying (LDA)name and state
Lobbying clientMOMENTA PHARMACEUTICALS, INC.MAFederal lobbying (LDA)name and state
Patent assigneeMomenta Pharmaceuticals, Inc.MAPatents (USPTO)name and state
SEC filerMOMENTA PHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerMomenta Pharmaceuticals, Inc.MATrademarks (USPTO)name and state
Form 5500 plan sponsorMOMENTA PHARMACEUTICALS, INC.EIN (EXACT)
Person pageCraig A WheelerPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)
Person pageJose-Carlos Gutierrez-RamosPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pagePaul D Goldenheim MdPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageRichard P SheaPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer)
Person pageThomas P KoestlerPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), MA first:

More with this interest.

In other datasets, the same topic (Health) in MA:

Interests: Biological Products, (No Diagnostic Substances) · Health